Skip to content

Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method

Bleb Function and Morphology With Intratendon Injection of 0.1 mg MMC in Comparison With Conventional Subtenon Application of 0.02% MMC Soaked Sponges in Trabeculectomy

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02385370
Acronym
conj mmc
Enrollment
126
Registered
2015-03-11
Start date
2014-12-31
Completion date
Unknown
Last updated
2015-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

Patients with advanced glaucoma that are candidates for trabeculectomy will be included. Thorough ophthalmic examination including best corrected visual acuity, slit lamp examination, intraocular pressure (IOP) measurement, gonioscopy, funduscopy and specularly microscopy will be performed for all participants. Patients will be assigned randomly to 2 groups. In one group they will undergo fornix based trabeculectomy with conventional MMC 0.02% soaked sponges application. In the other group 0.1 cc of 0.01 MMC will be injected into the tenon at the beginning of the surgery. The rest of the operation is the same for both groups as standard trabeculectomy. Ophthalmic examination including IOP measurement will be performed at one, 3 and 6th month post surgery. Specular microscopy will be requested at final follow up visit. Bleb morphology will be scored according to Indian grading system at 3rd and 6th months post surgery.

Interventions

DRUGMMC

using 0.02 MMC soaked sponged under the conjunctiva for 1 to 3 minutes

Sponsors

Shahid Beheshti University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Advanced uncontrolled glaucoma patients.

Exclusion criteria

* History of any kind of intraocular surgery. * Monocular patients. * Unwillingness to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
IOP (intraocular pressure)until 6 monthsGoldmann applanation tonometry

Secondary

MeasureTime frameDescription
Bleb morphologyuntil 6 monthsscoring the bleb morphologic features according to Indian Grading System

Countries

Iran

Contacts

Primary Contactmohammad pakravan
labbafi@hotmail.com009822591616

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026